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Abstract 
Background: Myotubularin‑related protein 14 (MTMR14) is a novel phosphoinositide phosphatase with roles in the 
maintenance of normal muscle performance, autophagy, and aging in mice. Our initial pilot study demonstrated that 
MTMR14 knock out (KO) mice gain weight earlier than their wild‑type (WT) littermates, which suggests that this gene 
may also be involved in metabolism regulation.
Results: The present study evaluated the role of MTMR14 in the development of aging‑associated obesity. We found 
that aged MTMR14 KO mice fed a normal chow diet exhibited increased serum triglyceride, total cholesterol, and glu‑
cose levels compared to age‑matched WT controls. Lipid accumulation was also increased in aged KO mice. Several 
inflammatory cytokines and adipokines were dramatically dysregulated in the metabolic tissues of aged MTMR14 KO 
mice compared to control mice. Circulating inflammatory cytokines were significantly elevated and plasma adipokine 
levels were abnormally regulated in aged MTMR14 KO mice. These data suggest that MTMR14 deficiency caused a 
late‑onset inflammation and metabolic dysfunction. Further study demonstrated that this exacerbated metabolic 
dysfunction and inflammation may be regulated by the phosphoinositide 3 kinase/protein kinase B and extracellular 
signal‑regulated protein kinase signaling pathways.
Conclusions: Our current research suggests that MTMR14 deletion induces overweight and adult obesity accompa‑
nied by chronic inflammation in an age‑dependent manner.
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Background
In 2014, the World Health Organization (WHO) has pre-
dicted that approximately 2–3 billion adults will be over-
weight; 700 million adults will be obese, and 200 million 
school-aged children will be obese/overweight [1]. The 
global increase in the prevalence and incidence of obesity 
has drawn attention to this issue as a major public health 
concern. Obesity is commonly attributed to increased 
body weight, accumulated fat, metabolic complications, 
and chronic systemic inflammation [2, 3]. Obesity is 
associated with various chronic diseases, including meta-
bolic syndrome, cardiovascular diseases, diabetic retin-
opathy, respiratory disease, and cancer [4]. It is widely 
accepted that the cause of the obesity epidemic is a conse-
quence of rapid changes in environment and lifestyle, but 
it is not clear why some individuals are more susceptible to 
an obesogenic environment than others [5, 6]. The major 
risk factors for obesity are environmental and genetic, and 
several candidate genes are involved in obesity in mice 
and humans, including glucose transporter type 4 (Glut4), 
leptin, adiponectin, tumor necrosis factor (TNF-α), inter-
leukin 6 (IL-6), interleukin 1β (IL-1β), monocyte chemot-
actic protein 1 (MCP-1), glucose-6-phosphate (G6P), and 
phosphoenolpyruvate carboxykinase (PEPCK) [1, 7–11].
Myotubularin-related protein 14 is a novel phos-
phoinositide phosphatase. An inactivation mutation of 
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MTMR14 was first identified in human centronuclear 
myopathy in 2006 [12, 13], suggesting that this gene is 
involved in muscle disease. Deletion of MTMR14 in mice 
disrupts calcium homeostasis and causes a muscle disor-
der [14]. MTMR14 is also involved in the regulation of 
autophagy and aging [15–19]. Our recent work revealed 
that MTMR14 KO mice weighed more than their WT 
littermates as adults, especially aged mice, which sug-
gests that MTMR14 is involved in the regulation of body 
weight and metabolism.
We used MTMR14 KO male mice as a working model 
to investigate the mechanism of MTMR14 in obesity. 
A series of physiological indexes demonstrated that the 
loss of MTMR14 induced obesity in an age-depend-
ent manner, as reflected by body weight, energy intake 
and expenditure, blood biochemical indexes, and fat 
accumulation. Further research demonstrated that the 
PI3K/AKT and ERK signaling pathways are involved in 
MTMR14 deletion-regulated obesity.
Results and discussion
MTMR14 KO mice got fat earlier than WT mice
Our previous results demonstrated that MTMR14 KO 
mice were born at the expected Mendelian ratio and did 
not exhibit obvious abnormalities [14]. WT and MTMR14 
KO mice were identified through PCR genotyping. As 
we expected, MTMR14 mRNA and protein were almost 
undetectable in the metabolic tissues of male KO mice 
at different ages (Fig. 1b, c). Then the growth curve, daily 
energy intake and expenditure were measured at differ-
ent time points of male WT and MTMR14 KO mice fed 
a normal chow diet (Fig.  1d–f; Table  1). Growth curve 
analyses revealed that genotype and age significantly 
affected weight (p  <  0.001). A significant interaction of 
genotype and age was also observed (p < 0.001). Figure 1d 
shows that no large differences were recorded when the 
mice were younger than 12  weeks. However, MTMR14 
KO mice had more body fat than the WT controls after 
12  weeks (p  <  0.05), and the difference was more dra-
matic (p  <  0.01) with increased age. We measured daily 
energy intake and expenditure in age-matched WT and 
MTMR14 KO mice (Fig. 1e, f ). Daily food intake revealed 
no significant difference between WT and MTMR14 KO 
mice (Fig.  1e). Further analyses of energy expenditure 
demonstrated that aged MTMR14 KO mice lost less body 
weight than WT mice (Fig.  1f ). These results indicated 
that aged MTMR14 KO mice developed obesity as a result 
of reduced energy expenditure.
MTMR14 KO mice exhibited increased serum TG, TC, 
and glucose levels in an age‑dependent manner
Obesity arises from an imbalance in energy intake and 
expenditure that eventually leads to the pathological 
growth of adipocytes [20]. We monitored serum TG, TC, 
and blood glucose levels and glucose tolerance to clarify 
the possible metabolic complications associated with 
the obese phenotype in the aged MTMR14 KO mice. 
MTMR14 KO mice exhibited a marked elevation in fast-
ing serum TG levels at an earlier age (4 weeks) compared 
to control mice. Fasting TG levels in MTMR14 KO mice 
were sustained higher than age-matched WT controls 
after 30 weeks of feeding a normal chow diet (Table 1). 
No distinguishable differences in serum TC levels were 
recorded when the mice were young (≤18  weeks), but 
fasting serum TC levels were significantly higher in 
MTMR14 KO mice at 34  weeks of age than controls 
(Table 1).
Glucose tolerance tests (GTTs) were performed in 
4-week-, 18-week- and 34-week-old WT and MTMR14 
KO mice (Fig.  2; Table  1). Statistical analysis revealed 
that genotype and age significantly affected blood glucose 
level (p < 0.001). A significant interaction of genotype and 
age was observed (p  <  0.001). In aged mice (34  weeks), 
genotype and minutes after injection both significantly 
affected blood glucose level (p  <  0.001), A significant 
interaction of genotype and minutes after injection was 
also observed (p  <  0.01). Glucose level and tolerance in 
MTMR14 KO mice were not significantly different after 
an exogenous glucose challenge at an early age (4 weeks) 
compared to WT littermates (Fig.  2a). Similarly, fast-
ing glucose levels were almost undistinguishable after 
glucose injections in the adult test group (18  weeks). 
However, basal glucose levels were significantly higher 
in 18-week-old MTMR14 KO mice than WT con-
trols (Fig.  2b). The most severe glucose intolerance was 
observed with aging (Fig. 2c). In aged MTMR14 KO mice 
(34  weeks), higher glucose levels were observed com-
pared with WT mice in 0, 15, 30, 60, 120 min after injec-
tion, respectively. These results suggest that MTMR14 
deficiency impairs glucose and lipid metabolism even in 
mice fed a normal chow diet and that the metabolic dis-
orders become severe with aging.
MTMR14 KO mice exhibit exacerbated fat accumulation
Fat accumulation and adipocyte differentiation are asso-
ciated with the occurrence and development of obesity 
[10]. As shown in Fig.  3a, histological analysis revealed 
that there were no obvious differences in fat accumula-
tion between 4-week-old KO and WT mice. The livers 
of 18-week-old MTMR14 KO mice exhibited a subtle 
accumulation of visceral adipose tissue compared to 
WT littermates, and an obvious lipid accumulation 
was observed in 34-week-old WT mice. In contrast, 
MTMR14 KO mice exhibited a dramatically exacer-
bated accumulation of visceral adipose tissue (Fig.  3a). 
The visceral fat pad (% of body weight) exhibited no 



























































































































































Fig. 1 Growth curve, energy intake and energy expenditure of WT and MTMR14 KO mice. Mice in these experiments were fed a standard chow 
diet. a PCR genotyping results of WT and MTMR14 KO mice. b, c MTMR14 mRNA and protein expression levels in three metabolic tissues of WT and 
KO mice at different ages (4, 18 and 34 weeks), respectively. d The growth curve of WT and MTMR14 KO mice. Body weights of WT and MTMR14 KO 
mice were measured at 4, 12, 18, 24, and 34 weeks of age. e The daily food intake of WT and MTMR14 KO mice was measured in an age‑matched 
manner (4, 18 and 34 weeks). f The amount of 12 h fasting‑induced body weight change in WT and MTMR14 KO mice was calculated as an approxi‑
mation of energy expenditure. The values are expressed as the mean ± SD. *p < 0.05, **p < 0.01, n = 8
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significant differences in young mice (≤18  weeks), but 
the percentage in aged MTMR14 KO mice was signifi-
cantly increased compared to that in the WT control 
(Fig. 3b; Table 1). Further histological analyses of meta-
bolic tissues revealed that the size of adipocytes in aged 
MTMR14 KO mice increased compared to those in WT 
mice (Fig.  3c). More lipid droplets accumulated in the 
myocytes and hepatocytes of 34-week-old MTMR14 KO 
mice (Fig.  3d), and hepatic steatosis was also observed 
(Fig. 3c, d). These data demonstrated that MTMR14 defi-
ciency promoted hepatic steatosis, lipid droplet accumu-
lation and increased adipocyte size in aged MTMR14 KO 
mice.
MTMR14 deficiency down‑regulated 
metabolism‑associated factors and up‑regulated 
inflammation‑related gene expression in the fat tissue 
of aged mice
Fat and muscle are important tissues for energy stor-
age and utilization. Glut4, adiponectin, and leptin are 
important genes that play positive roles in the regulation 
of obesity and body metabolism [12, 21, 22]. We investi-
gated whether the expression of these genes was affected 
in MTMR14 KO mice. The expression level of Glut4 
decreased in MTMR14 KO mice at every stage compared 
to that in their WT littermates (Fig.  4a). Adiponectin 
and leptin mRNA expression was only reduced in aged 
MTMR14 KO mice (Fig.  4b, c). Obesity is a systemic, 
low-grade, chronic inflammatory reaction. Therefore, 
we examined the expression of typical pro-inflammatory 
cytokines, including TNF-α, IL-6, IL-1β, and MCP-1 
[23]. The mRNA level of TNF-α was elevated in young 
and aged MTMR14 KO mice compared to WT controls 
(Fig.  4d), and IL-6 exhibited a higher expression level 
in MTMR14 KO mouse fat at every age (Fig.  4e). The 
mRNA expression of IL-1β was also increased in older 
MTMR14 KO mice (Fig. 4f ), and the expression level of 
MCP-1 was significantly increased in adult MTMR14 KO 
mice (Fig. 4g).
MTMR14 deficiency down‑regulated 
metabolism‑associated factors and up‑regulated 
inflammation‑related gene expression in the muscle 
of aged mice
Quantitative PCR of muscle demonstrated that the 
expression levels of Glut4 and leptin were lower in 
MTMR14 KO mice of every age (Fig.  5a, c). Adiponec-
tin expression in adult MTMR14 KO mice also decreased 
(Fig.  5b). In contrast to adipokines, inflammatory 
cytokine expression was up-regulated in the muscle of 
MTMR14 KO mice (Fig.  5d–f). MCP-1 was not signifi-
cantly different in MTMR14 KO mice at any age (Fig. 5g).
MTMR14 deficiency dysregulated metabolism 
and inflammation‑associated gene expression in aged 
mouse liver
The liver plays a vital role in metabolism and detoxi-
fication. Figure  6 shows that adipokine mRNA levels 
Table 1 Metabolic and inflammatory variables in MTMR14 WT and KO mice
Body weight, daily food intake, body weight change, TG, TC, blood glucose level, fat mass/body weight, plasma TNF-α, IL-6, leptin and adiponectin of age-matched WT 
and KO mice were evaluated. Data are mean ± SD of 7–8 mice per group. All WT and KO data were statistically analyzed in an age-matched manner
* p < 0.05, ** p < 0.01, *** p < 0.001 vs. the respective WT group
Variables WT KO
4 weeks 18 weeks 34 weeks 4 weeks 18 weeks 34 weeks
Body weight (g) 16.2 ± 0.2 27.4 ± 0.3 36.1 ± 3.1 17.5 ± 2.3 32.2 ± 2.1* 51.9 ± 4.9**
Daily food intake (g/mouse) 2.37 ± 0.14 2.98 ± 0.19 3.57 ± 0.15 2.41 ± 0.41 2.88 ± 0.22 3.51 ± 0.16
Body weight change (% of initial weight) −10.16 ± 1.6 −8.4 ± 0.2 −8.26 ± 0.7 −10.23 ± 1.1 −8.54 ± 1.0 −5.84 ± 0.8*
TG (mg/dL) 96.49 ± 18.54 106.35 ± 19.80 115.78 ± 14.22 108.25 ± 17.64* 112.45 ± 16.73* 124.26 ± 23.61*
TC (mg/dL) 88.78 ± 14.43 91.57 ± 16.72 95.59 ± 17.35 87.35 ± 12.62 94.68 ± 14.24 106.93 ± 18.16 *
Blood glucose (0 min) (mg/dL) 69 ± 4 53 ± 4 61 ± 8 77 ± 13 72 ± 6* 81 ± 5*
Blood glucose (15 min) (mg/dL) 229 ± 25 224 ± 22 172 ± 8 243 ± 24 220 ± 11 251 ± 13**
Blood glucose (30 min) (mg/dL) 202 ± 11 206 ± 17 155 ± 11 210 ± 19 221 ± 23 208 ± 22*
Blood glucose (60 min) (mg/dL) 176 ± 14 166 ± 18 116 ± 10 178 ± 20 186 ± 8 157 ± 12*
Blood glucose (120 min) (mg/dL) 141 ± 6 107 ± 4 91 ± 13 139 ± 13 130 ± 14 124 ± 11*
Fat mass/body weight (mg/g) 20.82 ± 0.91 30.42 ± 0.79 22.96 ± 1.29 21.46 ± 0.82 31.23 ± 0.84 27.48 ± 1.22**
TNF‑α (pg/mL) 1168 ± 184 1331 ± 146 1705 ± 182 1207 ± 193 1428 ± 173 3407 ± 289***
IL‑6 (pg/mL) 176 ± 30 215 ± 13 316 ± 13 180 ± 31 210 ± 42 556 ± 107**
Leptin (pg/mL) 6615 ± 409 7150 ± 522 8678 ± 425 5767 ± 401 9025 ± 735 20436 ± 422***
Adiponectin (ng/mL) 379 ± 48 384 ± 64 308 ± 47 350 ± 29 329 ± 34 141 ± 27***
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increased dramatically in the livers of MTMR14 KO mice 
(Fig. 6a–c). We also found that TNF-α and IL-6 mRNA 
levels were increased in MTMR14 KO mice even at an 
early age (Fig. 6d, e). IL-1β and MCP-1 mRNA levels were 
indistinguishable between WT and MTMR14 KO mice 
at an early age (4  weeks), but these levels decreased in 
aged MTMR14 KO mice (≥18 weeks) (Fig. 6f, g). PEPCK 
and G6P, which produce insulin-responsive enzymes of 
hepatic glyceroneogenesis [24], exhibited significantly 
higher mRNA levels in MTMR14 KO mice at 18 weeks, 
and these levels were sustained at 34 weeks (Fig. 6h, i).
These results demonstrate that the loss of MTMR14 
promoted metabolic dysfunction and inflammation in 
fat, muscle and liver, particularly in aged mice.
MTMR14 deficiency altered serum inflammatory cytokine 
and adipokine expression
Figures  4, 5 and 6 show that MTMR14 deletion evoked 
a dysregulation of several metabolic- and inflammation-
associated genes in fat, muscle and liver. Plasma inflam-
matory cytokine and adipokine levels were measured to 
examine the overall influence of abnormal expression 
patterns in metabolic tissues (Fig. 7; Table 1). Circulating 
inflammatory cytokines, TNF-α and IL-6 were dramati-
cally increased only in aged MTMR14 KO mice (Fig. 7a, 
b). Plasma leptin levels were also elevated in aged 
MTMR14 KO mice (Fig.  7c), but adiponectin exhibited 
an obvious reduction in these mice compared to their 
WT littermates (Fig.  7d). Plasma leptin and adiponec-
tin levels were not significantly different in young mice 
(≤18 weeks). These results indicated that MTMR14 defi-
ciency may lead to late-onset inflammation and abnor-
mal metabolism.
MTMR14 deficiency dysregulated PI3K/AKT and ERK 
signaling pathways in adipose tissue, muscle, and liver
The phosphoinositide 3 kinase/protein kinase B (PI3K/
AKT) and extracellular signal-regulated protein kinase 
(ERK) signaling pathways are important in obesity, 
inflammation and associated chronic diseases. The acti-
vation of two critical protein kinases in PI3K/AKT and 
ERK signaling pathways, ERK and AKT, plays an impor-
tant role in cell cycle, proliferation, apoptosis, and 
autophagy [25–28]. The current study investigated ERK 
and AKT phosphorylation in three tissues of MTMR14 
KO and WT mice. In fat, Glut4, which is a vital glucose 
transporter in insulin response, was decreased in adult 
and aged MTMR14 KO mice (Fig.  8a) and the phos-
phorylation level of ERK (p-ERK) was increased in aged 
MTMR14 KO mice (Fig.  8b). An elevated phosphoryla-
tion of AKT (p-AKT) in fat tissue in aged MTMR14 KO 
mice was also observed (Fig. 8c).
In muscle, the expression of Glut4 was significantly 
decreased in adult and aged MTMR14 KO mice com-
pared with WT littermates (Fig.  8d). Similarly, p-ERK 
protein levels were significantly reduced in muscle tis-
sue in 4-week-old and 34-week-old MTMR14 KO mice 
(Fig. 8e), and the levels of p-AKT were increased in KO 
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Fig. 2 Glucose tolerance in WT and MTMR14 KO mice. a–c Glucose 
tolerance tests were performed in WT and MTMR14 KO mice at 4, 18 
and 34 weeks. For GTT experiments, 2 g d‑glucose/kg body weight 
was administered to 12‑h fasted WT and MTMR14 KO mice in an 
age‑matched manner, and blood glucose levels were sampled from 
venous tail blood at the indicated time‑points. *p < 0.05, **p < 0.01, 
n = 7
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Fig. 3 MTMR14 deletion exacerbated fat accumulation. a Pictures of visceral fat pad from WT and MTMR14 KO male mice at 4, 18, and 34 weeks of 
age. b The fat mass (% of body weight) in WT (blue) and MTMR14 KO (red) male mice at different ages. c metabolic tissues (fat, muscle, liver) of WT 
and MTMR14 KO male mice at 18 weeks old or 34 weeks old was collected and stained with hematoxylin‑eosin (H&E). d Histology of fat, muscles 
and livers of WT and MTMR14 KO male mice using Oil Red O staining. Pictures were taken under ×400 magnifications
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In liver tissue, the expression of Glut4 was markedly 
increased in adult and aged MTMR14 KO mice (Fig. 8g). 
p-ERK levels were increased in liver tissue in young and 
aged MTMR14 KO mice, but p-ERK was reduced at 
18 weeks (Fig. 8h). AKT phosphorylation was sustained 
at a higher expression level in liver tissue in MTMR14 KO 
mice at every age compared to WT littermates (Fig. 8i).
These data demonstrated that MTMR14 deficiency 
evoked dysfunction in the PI3K/AKT signal pathway. How-
ever, the detailed mechanisms require further investigation.
Discussion
Energy imbalance exerts a negative effect on body con-
ditions and evokes numerous health problems, including 
diabetes, cardiovascular diseases and cancer. Current 
research focuses on certain people who seem healthy 
with normal body weight and limited physiological 
symptoms at a young age but develop extra body fat and 
severe blood chemical indexes as adults, which leads to 
inflammation and metabolic dysfunction (i.e., “adult 
obesity”). Adult obesity has a negative influence on peo-
ple’s health, work and quality of life, and it creates a huge 
financial burden on government medical care systems. 
Recent research has indicated that excess calorie intake, 
little physical exercise and obesity genes are important 
factors contributing to obesity.
MTMR14 is a newly identified phosphoinositide phos-













































































































































Fig. 4 MTMR14 deficiency down‑regulated metabolism‑associated genes but up‑regulated inflammation‑associated gene expression with age in 
fat. a–c The expression levels of mRNAs related to metabolism (Glut4, adiponectin, leptin) and d–g inflammation (TNF‑α, IL‑6, IL‑1β, MCP‑1) in the fat 
of WT (blue) and MTMR14 KO (red) mice at different ages (4, 18, and 34 weeks) were detected. *p < 0.05, **p < 0.01, ***p < 0.001
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centronuclear myopathy [12]. MTMR14 favors a variety 
of phosphatidylinositol phosphates (PIPs) as substrates, 
such as PI (3, 4) P2, PI (3, 5) P2, and PI (4, 5) P2 [14]. 
MTMR14 is highly expressed in the heart, muscles and 
testis, but it is also detected in the kidney, placenta, fat 
and liver. The functions of MTMR14 primarily include 
cell autophagy and proliferation, muscle disease and 
aging [14–16, 18, 19, 29–31]. Our pilot studies found that 
MTMR14 KO mice accumulate more fat than WT mice 
in adulthood. However, the exact role of MTMR14 in fat 
accumulation is largely unknown.
The current study included a series of experiments 
to delineate the potential role of MTMR14 in obe-
sity. Mice were divided into five major groups based 
on age: childhood (4  weeks), adolescence (12  weeks), 
adulthood (18  weeks), middle-aged (24  weeks) and old-
aged (34  weeks). A series of physiological indexes were 
measured in age-matched MTMR14 KO mice and their 
WT littermates. The results demonstrated that aged 
MTMR14 KO mice (34  weeks) exhibited significantly 
higher body weights than WT littermates due to reduced 
energy expenditure. An increased ratio of fat mass to 
body weight was also observed in aged MTMR14 KO 
mice, which was accompanied by higher TC and TG 
levels, elevated glucose levels, larger adipocytes, and 
more lipid droplet accumulation in liver and muscle, as 
revealed by anatomical and histological analyses. These 
data demonstrated that MTMR14 deletion induced 
late-onset obesity in mice fed a normal chow diet and 













































































































































Fig. 5 MTMR14 deficiency down‑regulated metabolism‑associated genes but up‑regulated inflammation‑associated gene expression with age 
in muscle. a–g Real‑time PCR analysis of Glut4, adiponectin, leptin, TNF‑α, IL‑6, IL‑1β, and MCP‑1 mRNA levels in muscles. *p < 0.05, **p < 0.01, 
***p < 0.001
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accumulate in adulthood. Obesity also became more 
severe with age.
Fat, muscle and liver are important tissues that regulate 
energy balance and metabolism. However, these tissues 
play diverse roles in physiological processes. Notably, 
we found that the mRNA expression of inflammatory 
cytokines and adipokines was specific to metabolic tissue. 
For example, leptin expression was down-regulated in fat 
and muscle but up-regulated in liver. The altered expres-
sion patterns of adipokines and inflammatory cytokines 
between liver and fat/muscle may be explained by two 
hypotheses. First, the different functions of these three 
tissues are determined by different mRNA expression 





































































































































































































Fig. 6 MTMR14 deficiency up‑regulated metabolism‑ and inflammation‑associated gene expression with age in the liver. a–i The expression levels 
of Glut4, adiponectin, leptin, TNF‑α, IL‑6, IL‑1β, MCP‑1, PEPCK and G6P in the livers of WT blue) and MTMR14 KO (red) mice at different ages (4, 18, 
and 34 weeks) were detected. *p < 0.05, **p < 0.01, ***p < 0.001
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chronic inflammatory state as a result of a comprehen-
sive effect. Serum inflammatory cytokines and adi-
pokines were measured to confirm this hypothesis, and 
the results demonstrated that circulating TNF-α and 
IL-6 levels were significantly elevated in aged MTMR14 
KO mice compared to age-matched WT controls. These 
results indicate an increased inflammatory state in aged 
MTMR14 KO mice. The reduction of adiponectin in aged 
MTMR14 KO mice demonstrated a severe inflamma-
tion and metabolic disorder during aging. Notably, aged 
MTMR14 KO mice exhibited higher plasma leptin levels, 
which is consistent with the excessive fat accumulation in 
these mice. Circulating leptin enables the long-term reg-
ulation of fat accumulation via pathways that arise from 
the hypothalamus [32]. However, our previous finding 
[14] revealed that MTMR14 was scarce in brain tissue. 
Therefore, we presumed that MTMR14 plays an indirect 
role in hypothalamus-mediated metabolic dysfunctions. 
Taken together, our findings suggest that MTMR14 defi-
ciency evokes severe inflammation via the up-regulation 
of TNF-α and IL-6, and the metabolic disorders may 
depend on elevated leptin and decreased adiponectin. 
Furthermore, the inflammation and abnormal metabo-
lism occurred in an age-dependent manner.
Second, the liver is a vital organ for protein synthesis 
and metabolic detoxification, and it plays a compen-
sative role [33, 34] when metabolic dysfunction and 
inflammation impair the normal functions of muscle and 
fat. However, the decompensation of liver occurred when 
hepatic steatosis was increased in adult MTMR14 KO 
mice. The elevated MCP-1 expression level in adipose tis-
sue and increased TNF-α, PEPCK and G6P levels in liver 
[35] verified the high glyceroneogenesis and hepatic stea-
tosis state in aged MTMR14 KO mice in our study.
The PI3K/AKT and ERK signaling pathways are vital 
in numerous inflammation-evoked chronic diseases [36]. 
Activated PI3K in the PI3K/AKT and ERK signaling path-
ways produces PI (3,4,5) P3 to phosphorylate AKT and 
regulate ERK phosphorylation [37–39]. Dysfunction of 
the PI3K/AKT and ERK signaling pathways was observed 
in the KO mice in the current study. Levels of p-ERK and 
p-AKT in immature MTMR14 KO mice were down-reg-
ulated in muscle but up-regulated in liver compared to 
WT littermates. The levels of p-ERK were reduced in the 
liver in adult KO mice, and p-AKT levels were elevated 
in muscle and liver. The compensative function of the 
liver was also observed when MTMR14 KO mice were 
young, but the inflammatory state was not obvious. The 
expression of p-ERK decreased in muscle and increased 
in liver and fat with age, but p-AKT was elevated in all 
three tissues. Generally, MTMR14 deficiency promoted 
the phosphorylation of AKT and ERK in aged KO mice, 
and evoked a crosstalk between adipose tissue and 



















































































4 weeks 18  weeks 34 weeks
Fig. 7 MTMR14 deficiency influenced plasma concentrations of inflammatory cytokines and adipokines. a–d The plasma levels of TNF‑α, IL‑6, leptin 
and adiponectin in WT (blue) and MTMR14 KO (red) mice were measured in an age‑matched manner (4, 18, and 34 weeks). **p < 0.01, ***p < 0.001






































































































































































































































































































Fig. 8 MTMR14 deficiency altered PI3K/AKT and ERK signaling pathways in fat, muscle and liver. a Expressions levels of Glut4 in fat. b, c The phos‑
phorylation levels of ERK and AKT in fat of WT and MTMR14 KO mice at different ages (4, 18, and 34 weeks) were detected. d The expression levels 
of Glut4 in muscles of MTMR14 WT and KO mice. e, f The phosphorylation levels of ERK and AKT in muscles of WT and MTMR14 KO mice at different 
ages (4, 18, and 34 weeks) were detected. g The expression levels of Glut4 in the livers of MTMR14 WT and KO mice. h, i The phosphorylation levels 
of ERK and AKT in livers of WT and MTMR14 KO mice at different ages (4, 18, and 34 weeks) were detected. Quantitative measurements of Glut4, 
p‑ERK, p‑ARK proteins in fat, muscle and liver tissue of WT (blue) and KO (red) mice are shown underneath the original pictures. *p < 0.05, **p < 0.01, 
***p < 0.001. β‑actin was included as a control
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metabolic disorders. Taken together, as shown in Fig. 9, 
MTMR14 deletion evokes inflammation, metabolic dis-
order and obesity by dysregulations of certain vital genes, 
alterations of PI3K/AKT and ERK signaling pathway and 
releases of serum cytokines.
Similar to the phosphatase and tensin homolog 
(PTEN), MTMR14 dephosphorylated several PIPs, which 
suggests that MTMR14 plays an antagonistic role in 
the PI3K/AKT and ERK signaling cascades. However, a 
spatio-temporal dysregulation of p-AKT and p-ERK was 
observed in our research. A recent report [40] demon-
strated that same stimulus (cytokines, inhibitor, serum, 
siRNA) increased cell-to-cell variations in p-AKT and 
p-ERK signals, which determined different cell fates. This 
observation may explain how MTMR14 deletion evoked 
different tissue-to-tissue expression in different stage and 
help researchers to draft a p-AKT and p-ERK response 
map for obesity.
Our previous study demonstrated that MTMR14 dele-
tion impaired calcium homeostasis and elevated calcium 
concentrations [14]. Recent studies has reported that 
elevated intracellular calcium could release extracellular 
inflammatory cytokines and induce obesity and com-
plications [41, 42]. Taken together, MTMR14 deficiency 
could induce PIP3 production-mediated AKT/ERK phos-
phorylation and ryanodine receptor (RyR) activation-
mediated intracellular calcium release. Alterations in 
the PI3K/AKT and ERK signal pathways, disruptions 
of calcium homeostasis, and releases of circulating 
cytokines indicated a state of inflammation and meta-
bolic disorder, which induced obesity and complications. 
Our previous research also indicated that MTMR14 dele-
tion promote cell autophagy through elevating the phos-
phorylation levels of AKT and ERK [31]. Recent studies 
have reported that cell autophagy is closely associated 
with inflammation, and several inflammatory cytokines, 
such as TNF-α, IL-6, have been identified as autophagy 
modulators [43]. Further investigations are needed to fig-
ure out the molecular and cellular connections between 
autophagy and inflammation especially via PI3K/AKT 
and ERK signaling pathway in MTMR14 deficiency 
induced chronic diseases.
Notably, this research was performed using normal 
chow diet. MTMR14 is highly expressed in the heart, and 
a high-fat diet (HFD) might induce a series of severe car-
diovascular diseases in MTMR14 KO mice.
In summary, we demonstrated that MTMR14 defi-
ciency led to adult obesity, metabolic dysfunction and 
inflammation with a normal chow diet, which was 
accompanied by the dysregulation of various inflam-
matory cytokines and adipokines and alterations in the 
PI3K/AKT and ERK signaling pathways in metabolic tis-
sues. These results improve our understanding of the role 
of MTMR14 in fat accumulation, metabolism and inflam-
mation and provide an important genetic target for the 
clinical diagnosis and treatment of adult obesity.
Methods
Mouse experiments
MTMR14+/− mice (C57BL/6J background) were gener-
ously provided by Dr. Cheng-Kui Qu from Case Western 
Reserve University. All housing and experiments were 
performed in accordance with the Guide for the Care and 
Use of Laboratory Animals of South-Central University 
for Nationalities. We used heterozygous and heterozygous 
intercrosses to maintain the MTMR14−/− mouse colony. 
The genotypes for each mouse were identified following 
the PCR genotyping method as described previously [14]. 
Experiments were conducted in a fasted state (except for 
the body weight experiment), with the food removed for 
12 h (from 8 PM to 8 AM) and free access to water.
Food intake and energy expenditure
Single WT or MTMR14 KO mice were housed in a cage 
containing a known amount of chow and new padding at 
8 PM, and food was reweighed at 8 PM on the following 
day [44]. Daily food intake was calculated using the fol-
lowing formula:
Daily food intake = foodweight at 8 PM
− foodweight at 8 PM the following day
MTMR14 
Deletion
Alteration of PI3K/AKT 
and ERK signaling
TNF IL 6 IL 1β MCP 1 l i di i
Dysregulation of gene expressions in 
metabolic tissues 










Inflammation Metabolic disorder Obesity
Fig. 9 Schema depicting the proposed mechanisms for MTMR14 
deletion‑induced obesity and complications. On one hand, MTMR14 
deletion dysregulates a number of genes then releases a series of 
inflammatory cytokines and adipokines. On the other hand, MTMR14 
deletion alters PI3K/AKT and ERK signaling pathway. As a result, 
MTMR14 deletion induces obesity and complications
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Energy expenditure was measured in age-matched 
fasted (12  h) mice as described previously [45]. Body 
weight changes were calculated using the following 
formula:
Determination of TG and TC levels
TG and TC levels were determined in plasma using com-
mercial kits from Biosystems (Barcelona, Spain). Blood 
samples for biochemical analysis were stored at −80  °C 
until use.
Glucose tolerance tests (GTTs)
Age-matched WT and MTMR14 KO mice were fasted for 
12  h with free access to water and subsequently injected 
intraperitoneally with 2  g d-glucose/kg (Sigma-Aldrich 
Co., St. Louis, MO, USA). Blood samples were taken from 
the tail vein prior to injection and at 15, 30, 60 and 120 min 
after injection. Glucose was measured using a glucometer 
(OneTouch UltraEasy, LifeScan Inc., Milpitas, CA, USA).
Histological analyses
A portion of liver, muscle and fat from age-matched 
WT and MTMR14 KO mice was frozen, sectioned and 
stained using Oil Red O or hematoxylin and eosin (H&E). 
Pictures from each sample were obtained at 400× magni-
fications and analyzed.
RNA extraction and real‑time PCR
Total RNA was isolated from various organs using TRI-
zol reagent (Invitrogen, Carlsbad, CA, USA), and quan-
titative RT-PCR analysis was performed using the SYBR 
Green Master Mix (TOYOBO, Tsuruga, Japan) and the 
7500 Fast QPCR system (Roche, Basel, Switzerland). The 
following primer sequences were used:






















































Whole blood was collected from the orbit after a 12-h 
fast and centrifuged (1000×g for 15 min). Serum was iso-
lated and analyzed using ELISAs for TNF-α (CUSABIO 
Biotech, Wuhan, China, CSB-E04741  m), IL-6 (CUSA-
BIO, CSB-E04639m), leptin (CUSABIO, CSB-E04650 m) 
and adiponectin (CUSABIO, CSB-E07272m). Briefly, 
serum samples and standards were loaded in a 48-well 
microplate for incubation with captured antibodies, and 
detection antibodies were applied. Streptavidin-horse-
radish peroxidase (HRP) and tetramethyl benzidine chro-
mogen were used to catalyze the color change reaction. 
Absorbance was measured at 450 nm.
Western blotting
Tissues were harvested and lysed in RIPA buffer 
[50  mM Tris–HCl, (pH 7.5), 120  mM NaCl, 0.5  % 
Nonidet P-40 supplemented with a protease inhibitor 
cocktail (Roche) and PhosSTOP Phosphatase Inhibitor 
Cocktail (Roche)]. Lysates were clarified using centrifu-
gation at 16,100×g for 15  min at 4  °C, and the super-
natant was collected as the protein lysate. Proteins were 
resolved using SDS–polyacrylamide gel electrophoresis 
and transferred to Immobilon-P membranes (Millipore, 
Boston, MA, USA). Membranes were blocked in TBST 
(10 mM Tris [pH 8.0], 150 mM NaCl, 0.1 % Tween 20) 
supplemented with 5  % (wt/vol) powdered milk and 
incubated with primary antibodies (1:1000 dilution) 
at 4  °C overnight. The membranes were washed three 
times with TBST at room temperature and incubated 
with a horseradish peroxidase-conjugated second-
ary antibody (1:20,000 dilution) (GE Healthcare, Lit-
tle Chalfont, Bucks, UK) for 1 h. Then, the membranes 
were washed with TBST three times, and signals were 
detected using ECL plus (GE Healthcare) according to 
the manufacturer’s protocol.
Data analysis
Results are expressed as mean ± SD. Differences between 
groups were estimated for statistical significance using 
a multivariate analysis of variance (ANOVA) or 2-tailed 
Student’s t test, and p < 0.05 was considered statistically 
significant.
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